These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 22968478)

  • 21. RGD inclusion in VP3 provides adeno-associated virus type 2 (AAV2)-based vectors with a heparan sulfate-independent cell entry mechanism.
    Shi W; Bartlett JS
    Mol Ther; 2003 Apr; 7(4):515-25. PubMed ID: 12727115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Redirecting AAV vectors to extrahepatic tissues.
    Asokan A; Shen S
    Mol Ther; 2023 Dec; 31(12):3371-3375. PubMed ID: 37805712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Engineering the AAV capsid to optimize vector-host-interactions.
    Büning H; Huber A; Zhang L; Meumann N; Hacker U
    Curr Opin Pharmacol; 2015 Oct; 24():94-104. PubMed ID: 26302254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rod Outer Segment Development Influences AAV-Mediated Photoreceptor Transduction After Subretinal Injection.
    Petit L; Ma S; Cheng SY; Gao G; Punzo C
    Hum Gene Ther; 2017 Jun; 28(6):464-481. PubMed ID: 28510482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In Search of Adeno-Associated Virus Vectors With Enhanced Cardiac Tropism for Gene Therapy.
    Sasaki N; Kok CY; Westhaus A; Alexander IE; Lisowski L; Kizana E
    Heart Lung Circ; 2023 Jul; 32(7):816-824. PubMed ID: 37451880
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pseudotyped adeno-associated viral vectors for gene transfer in dermal fibroblasts: implications for wound-healing applications.
    Balaji S; King A; Dhamija Y; Le LD; Shaaban AF; Crombleholme TM; Keswani SG
    J Surg Res; 2013 Sep; 184(1):691-8. PubMed ID: 23590866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of capsid modifications by selected peptide ligands on recombinant adeno-associated virus serotype 2-mediated gene transduction.
    Naumer M; Popa-Wagner R; Kleinschmidt JA
    J Gen Virol; 2012 Oct; 93(Pt 10):2131-2141. PubMed ID: 22764318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-Throughput
    Westhaus A; Cabanes-Creus M; Rybicki A; Baltazar G; Navarro RG; Zhu E; Drouyer M; Knight M; Albu RF; Ng BH; Kalajdzic P; Kwiatek M; Hsu K; Santilli G; Gold W; Kramer B; Gonzalez-Cordero A; Thrasher AJ; Alexander IE; Lisowski L
    Hum Gene Ther; 2020 May; 31(9-10):575-589. PubMed ID: 32000541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adeno-associated viral vectors and their redirection to cell-type specific receptors.
    Michelfelder S; Trepel M
    Adv Genet; 2009; 67():29-60. PubMed ID: 19914449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantifying transduction efficiencies of unmodified and tyrosine capsid mutant AAV vectors in vitro using two ocular cell lines.
    Ryals RC; Boye SL; Dinculescu A; Hauswirth WW; Boye SE
    Mol Vis; 2011 Apr; 17():1090-102. PubMed ID: 21552473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel adeno-associated viral vectors for retinal gene therapy.
    Vandenberghe LH; Auricchio A
    Gene Ther; 2012 Feb; 19(2):162-8. PubMed ID: 21993172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting photoreceptors via intravitreal delivery using novel, capsid-mutated AAV vectors.
    Kay CN; Ryals RC; Aslanidi GV; Min SH; Ruan Q; Sun J; Dyka FM; Kasuga D; Ayala AE; Van Vliet K; Agbandje-McKenna M; Hauswirth WW; Boye SL; Boye SE
    PLoS One; 2013; 8(4):e62097. PubMed ID: 23637972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coevolution of Adeno-associated Virus Capsid Antigenicity and Tropism through a Structure-Guided Approach.
    Havlik LP; Simon KE; Smith JK; Klinc KA; Tse LV; Oh DK; Fanous MM; Meganck RM; Mietzsch M; Kleinschmidt J; Agbandje-McKenna M; Asokan A
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32669336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modification and labeling of AAV vector particles.
    Büning H; Bolyard CM; Hallek M; Bartlett JS
    Methods Mol Biol; 2011; 807():273-300. PubMed ID: 22034035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved Genome Packaging Efficiency of Adeno-associated Virus Vectors Using Rep Hybrids.
    Mietzsch M; Eddington C; Jose A; Hsi J; Chipman P; Henley T; Choudhry M; McKenna R; Agbandje-McKenna M
    J Virol; 2021 Sep; 95(19):e0077321. PubMed ID: 34287038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retrograde gene transfer into neural pathways mediated by adeno-associated virus (AAV)-AAV receptor interaction.
    Sano H; Kobayashi K; Yoshioka N; Takebayashi H; Nambu A
    J Neurosci Methods; 2020 Nov; 345():108887. PubMed ID: 32739417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microvesicle-associated AAV vector as a novel gene delivery system.
    Maguire CA; Balaj L; Sivaraman S; Crommentuijn MH; Ericsson M; Mincheva-Nilsson L; Baranov V; Gianni D; Tannous BA; Sena-Esteves M; Breakefield XO; Skog J
    Mol Ther; 2012 May; 20(5):960-71. PubMed ID: 22314290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AAV-Mediated Gene Delivery to the Mouse Liver.
    Cunningham SC; Alexander IE
    Methods Mol Biol; 2019; 1937():213-219. PubMed ID: 30706398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation of Targeted Adeno-Associated Virus (AAV) Vectors for Human Gene Therapy.
    Liu Y; Siriwon N; Rohrs JA; Wang P
    Curr Pharm Des; 2015; 21(22):3248-56. PubMed ID: 26027561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful expansion but not complete restriction of tropism of adeno-associated virus by in vivo biopanning of random virus display peptide libraries.
    Michelfelder S; Kohlschütter J; Skorupa A; Pfennings S; Müller O; Kleinschmidt JA; Trepel M
    PLoS One; 2009; 4(4):e5122. PubMed ID: 19357785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.